For anyone recovering from opioid addiction, kratom use activates the same brain receptors and reward pathways that opioids do, making it a relapse by most clinical and recovery program standards. The answer isn’t purely semantic. Kratom’s active compounds bind to mu-opioid receptors, trigger dopamine release in the brain’s pleasure center, and can produce tolerance, withdrawal, and cravings that closely mirror traditional opioid dependence.
How Kratom Acts on the Brain
Kratom contains dozens of alkaloids, but two do the heavy lifting. The primary one, mitragynine, has a complex relationship with mu-opioid receptors: in lab settings it behaves as a low-efficacy agonist, meaning it activates the same receptor as heroin or oxycodone but with a weaker signal. The second, 7-hydroxymitragynine, is present in smaller amounts but is far more potent. It has roughly nine times higher binding affinity for mu-opioid receptors than mitragynine and acts as a partial agonist, producing effects that overlap substantially with conventional opioids.
What matters for the relapse question is what happens downstream. When these alkaloids activate opioid receptors, they stimulate the mesolimbic reward system, the same circuit that generates the pleasurable rush from heroin or prescription painkillers. A signal originates in the ventral tegmental area and triggers dopamine release in the nucleus accumbens, creating the feeling of reward that drives repeated use. A pilot study using brain imaging found that kratom-dependent individuals showed changes in dopamine transporter levels similar to those seen in people addicted to heroin, morphine, or codeine.
In practical terms, kratom is engaging the exact neurological machinery that addiction recovery aims to quiet.
Kratom Can Produce Its Own Addiction
Researchers have adapted the standard diagnostic checklist for substance use disorders to assess what they call “kratom use disorder.” The pattern looks familiar: people report using kratom in larger amounts or for longer than intended, continuing use specifically to avoid withdrawal, and experiencing cravings. Among those who meet the criteria, tolerance and withdrawal are the dominant features rather than social or occupational problems, which may explain why some users underestimate the severity of their dependence.
Withdrawal from kratom resembles opioid withdrawal in several respects, including runny nose, muscle pain, and diarrhea. It also overlaps with stimulant and sedative withdrawal, producing lethargy, depressed mood, and anxiety. Severity tends to be dose-dependent and is generally described as mild to moderate, but it is real enough to keep people using or to push them toward substituting other substances. Craving levels vary widely from person to person.
Why “It’s Just a Plant” Doesn’t Hold Up
The fact that kratom is derived from a leaf rather than synthesized in a lab has no bearing on whether it constitutes a relapse. Its alkaloids are pharmacologically active at opioid receptors, it triggers the brain’s reward circuitry, and it produces a withdrawal syndrome that in many respects resembles opioid withdrawal. The FDA has warned consumers against using kratom due to the risk of serious adverse events including liver toxicity, seizures, and substance use disorder itself. There are no FDA-approved kratom products of any kind on the U.S. market, whether as a drug, dietary supplement, or food additive.
Some kratom products also carry risks unrelated to the alkaloids themselves. The FDA has flagged contamination with Salmonella and concerning levels of heavy metals in commercial products. Because kratom occupies a regulatory gray zone, there is no standardized quality control, meaning the potency and purity of what you’re actually consuming can vary dramatically from one batch to the next.
The Substitution Trap
Many people turn to kratom specifically because they’re trying to manage opioid withdrawal or cravings on their own. Research on polysubstance users found that non-prescribed buprenorphine use explained about 36% of the statistical link between heroin use and kratom use, suggesting a pattern where people cycle through various opioid-receptor substances looking for something that controls withdrawal without the stigma or cost of formal treatment. The motivation is understandable, but the result is often a new dependency.
Kratom withdrawal effects, including pain, irritability, anxiety, and sleep disruption, can themselves push people toward continued use or toward picking up a stronger opioid when kratom stops being effective. This is the core danger of substitution without medical guidance: it maintains the cycle of opioid-receptor activation rather than breaking it.
Some researchers have noted that kratom carries less overdose risk than heroin and is unlikely to be injected, which makes it less immediately dangerous in some narrow harm-reduction scenarios. But “less likely to kill you today” is a very different standard from “compatible with recovery.” Case reports have documented people needing medication-assisted treatment to get off kratom itself, particularly during pregnancy.
What Recovery Programs Generally Say
Most 12-step programs and recovery communities define sobriety as abstinence from all mind-altering substances not prescribed by a physician for a legitimate medical condition. Kratom, which is not prescribed by physicians and not approved for any medical use in the U.S., falls outside that boundary. Using it to manage cravings or withdrawal, while understandable, reintroduces opioid-receptor stimulation and the dopamine-driven reward loop that sustains addiction.
If you’re in recovery and considering kratom, or already using it, the honest assessment is that your brain is experiencing something pharmacologically similar to the substance you’re recovering from. The dose is lower, the high is milder, and the risks are somewhat different in profile, but the fundamental mechanism is the same. For people recovering from opioid use disorder specifically, FDA-approved treatments like buprenorphine or methadone are administered under medical supervision with known dosing, verified purity, and clinical monitoring. Kratom offers none of those safeguards while activating the same receptors.